
|Articles|November 1, 1999
The American Journal of Managed Care
- November 1999
- Volume 5
- Issue 11
The Effect of a Copay Increase on Pharmaceutical Utilization, Expenditures, and Treatment Continuation
Advertisement
Articles in this issue
over 26 years ago
Doctor, I'm Having a Heart Attack, What Should I Do?over 26 years ago
Estimates of Costs of Primary Care Physician Turnoverover 26 years ago
Paying for HIV/AIDS Care at the Turn of the Centuryover 26 years ago
Developing a Managed Care Delivery System for People with HIV/AIDSAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
3
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
4
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
5




